Ledger.Open graph →
SEC Form D · Amendment · filed March 14, 2017

Lattice Biologics Ltd

Offering
$283K
Sold
$283K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SCOTTSDALE, AZ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Edward Van Brunt · Phoenix, AZDirectorAndrew Prozes · New York, NYExec · DirectorRobert Dahl · Greenwich, CTExec · DirectorMark R. Jarrell · New York, NYExec · DirectorNinggang T. Chen · Vienna, VAExec · DirectorMario Stifano · Scottsdale, AZDirectorDonald Mcinnes · Scottsdale, AZDirectorXiaoxue T. He · MCLEAN, VADirectorAkintoye Akindele · Ebene, O4DirectorMichael Spadafore · New York, NYDirectorCatherine Thomas · Scottsdale, AZDirectorGuy Cook · Scottsdale, AZExec · DirectorMichael Keriakos · NEW YORK, NYDirectorCheryl Farmer · Scottsdale, AZExec · DirectorSteven Elkes · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗